Sector portfolio · Private equity · Switzerland

Nextech Invest's Biotech portfolio

Nextech Invest has backed 10 Biotech startups in rounds we track, $2.3B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

10startups backed
2stages
$2.3Braised between them
Series Bbiggest stage

Nextech Invest's profile

Segment by segment

Series B

7 startups · $697M raised

  1. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  2. Neon TherapeuticsNEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.United States$161M
  3. Arrakis TherapeuticsArrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.United States$113M
  4. Kinnate BiopharmaKinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.United States$75M
  5. KTKhartis TherapeuticsUnited States$50M
  6. ImaginAbImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.United States$42M
  7. CBCleave BioscienceUnited States$37M

Series C and later

3 startups · $1.6B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. TTTP TherapeuticsUnited States$126M
  3. PPPMV PharmaUnited States$62M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Nextech Invest as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Nextech Invest?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.